JHS Svendgaard Laboratories Limited (NSE: JHS)
India
· Delayed Price · Currency is INR
27.72
-1.07 (-3.72%)
Oct 15, 2024, 3:30 PM IST
JHS Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Operating Revenue | 793.78 | 707.98 | 848.15 | 862.52 | 1,008 | 1,391 | Upgrade
|
Other Revenue | 42.29 | 20.95 | 63.45 | 9.59 | 2.05 | 25.28 | Upgrade
|
Revenue | 836.07 | 728.93 | 911.59 | 872.11 | 1,010 | 1,416 | Upgrade
|
Revenue Growth (YoY) | -10.85% | -20.04% | 4.53% | -13.63% | -28.71% | 11.63% | Upgrade
|
Cost of Revenue | 473.55 | 458.32 | 631.4 | 620.72 | 705.19 | 1,011 | Upgrade
|
Gross Profit | 362.51 | 270.61 | 280.2 | 251.39 | 304.51 | 405.51 | Upgrade
|
Selling, General & Admin | 94.06 | 97.64 | 120.49 | 117.54 | 107.38 | 190.18 | Upgrade
|
Other Operating Expenses | 194.64 | 154.92 | 186.44 | 105.2 | 121.02 | 156.88 | Upgrade
|
Operating Expenses | 358.68 | 316.03 | 367.1 | 293.26 | 300.95 | 434.67 | Upgrade
|
Operating Income | 3.84 | -45.42 | -86.9 | -41.87 | 3.55 | -29.16 | Upgrade
|
Interest Expense | -4.49 | -4.25 | -4.98 | -12.7 | -12.4 | -19.53 | Upgrade
|
Interest & Investment Income | - | 5.61 | 9.9 | 21.99 | 8.3 | 10.36 | Upgrade
|
Currency Exchange Gain (Loss) | - | -1.2 | 9 | 6.53 | -7.35 | 61.61 | Upgrade
|
Other Non Operating Income (Expenses) | - | -126.02 | 133.33 | 5.15 | 16.08 | 22.01 | Upgrade
|
EBT Excluding Unusual Items | -0.66 | -171.27 | 60.35 | -20.9 | 8.18 | 45.3 | Upgrade
|
Gain (Loss) on Sale of Investments | - | 2.85 | 0.7 | 1.53 | 2 | 2.44 | Upgrade
|
Gain (Loss) on Sale of Assets | - | 0.02 | 25.4 | 15 | -0.5 | -0.39 | Upgrade
|
Asset Writedown | - | - | - | - | - | -106.37 | Upgrade
|
Other Unusual Items | - | 6.95 | -183.62 | 5.4 | - | 0.6 | Upgrade
|
Pretax Income | -0.66 | -161.46 | -97.18 | 1.03 | 9.68 | -58.43 | Upgrade
|
Income Tax Expense | 20.33 | 6.29 | -54.28 | 43.92 | -3.75 | -9.88 | Upgrade
|
Earnings From Continuing Operations | -20.98 | -167.75 | -42.89 | -42.89 | 13.42 | -48.55 | Upgrade
|
Minority Interest in Earnings | - | 13.12 | 2.37 | 2.37 | -1.44 | 28.76 | Upgrade
|
Net Income | -20.98 | -154.64 | -40.52 | -40.52 | 11.98 | -19.79 | Upgrade
|
Net Income to Common | -20.98 | -154.64 | -40.52 | -40.52 | 11.98 | -19.79 | Upgrade
|
Shares Outstanding (Basic) | 78 | 78 | 78 | 64 | 61 | 61 | Upgrade
|
Shares Outstanding (Diluted) | 78 | 78 | 78 | 64 | 62 | 61 | Upgrade
|
Shares Change (YoY) | 16.71% | - | 21.89% | 4.34% | 1.22% | - | Upgrade
|
EPS (Basic) | -0.27 | -1.97 | -0.52 | -0.63 | 0.20 | -0.32 | Upgrade
|
EPS (Diluted) | -0.27 | -1.97 | -0.52 | -0.63 | 0.20 | -0.32 | Upgrade
|
Free Cash Flow | - | -401.17 | 89.43 | -158.75 | 36.96 | 0.84 | Upgrade
|
Free Cash Flow Per Share | - | -5.12 | 1.14 | -2.47 | 0.60 | 0.01 | Upgrade
|
Gross Margin | 43.36% | 37.12% | 30.74% | 28.83% | 30.16% | 28.63% | Upgrade
|
Operating Margin | 0.46% | -6.23% | -9.53% | -4.80% | 0.35% | -2.06% | Upgrade
|
Profit Margin | -2.51% | -21.21% | -4.44% | -4.65% | 1.19% | -1.40% | Upgrade
|
Free Cash Flow Margin | - | -55.04% | 9.81% | -18.20% | 3.66% | 0.06% | Upgrade
|
EBITDA | 68.55 | 12.8 | -26.74 | 28.65 | 60.52 | 44.93 | Upgrade
|
EBITDA Margin | 8.20% | 1.76% | -2.93% | 3.29% | 5.99% | 3.17% | Upgrade
|
D&A For EBITDA | 64.71 | 58.21 | 60.17 | 70.52 | 56.96 | 74.09 | Upgrade
|
EBIT | 3.84 | -45.42 | -86.9 | -41.87 | 3.55 | -29.16 | Upgrade
|
EBIT Margin | 0.46% | -6.23% | -9.53% | -4.80% | 0.35% | -2.06% | Upgrade
|
Effective Tax Rate | - | - | - | 4264.47% | - | - | Upgrade
|
Revenue as Reported | 836.07 | 751.13 | 961.36 | 956.42 | 1,083 | 1,529 | Upgrade
|
Advertising Expenses | - | 2.85 | 17.79 | 2.44 | 2.72 | 50.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.